• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

类风湿关节炎患者在疼痛管理方面存在的障碍可能导致疼痛控制不佳。

Patient barriers to pain management may contribute to poor pain control in rheumatoid arthritis.

作者信息

Fitzcharles Mary-Ann, DaCosta Deborah, Ware Mark A, Shir Yoram

机构信息

Montreal General Hospital Pain Centre, Montreal General Hospital, McGill University, Montreal, Quebec, Canada.

出版信息

J Pain. 2009 Mar;10(3):300-5. doi: 10.1016/j.jpain.2008.09.012. Epub 2008 Dec 13.

DOI:10.1016/j.jpain.2008.09.012
PMID:19070549
Abstract

UNLABELLED

We have examined the characteristics of the pain experience as well as barriers to optimal pain management in 60 patients with rheumatoid arthritis (RA) consecutively attending a specialist rheumatology practice. Pain was reported to be moderate to severe in 32 (53%) and mild to absent in 28 (47%). Sixty-five percent of all patients, including almost half of those with moderate to severe pain, reported satisfaction with current pain control. The average number of barriers to pain management for individual patients was 2.6 +/- 1.5, with 33 patients (55%) reporting 3 or more barriers. Specific barriers included concern about side effects of medications in 80%, dislike for "too many pills" in 63%, concern about drug interactions in 57%, fear of addiction in 35%, and fear of masking disease in 27% of the patients. More barriers were significantly associated with higher pain level (r = .33, P = .011) and pain intensity on a visual analogue scale (r = .29, P = .024). Other than the regular use of nonsteroidal anti-inflammatory drugs in 37% of the patients and acetaminophen in 37%, analgesics or other modalities to reduce pain were seldom used.

PERSPECTIVE

Moderate to severe pain was present in over half of patients with RA with many reporting the presence of considerable barriers to pain control. These barriers likely contribute to sub optimal pain management. RA patients tolerate pain and use limited mechanisms to deal with the symptom of pain.

摘要

未标注

我们对连续就诊于一家专业风湿病诊所的60例类风湿关节炎(RA)患者的疼痛体验特征以及最佳疼痛管理的障碍进行了研究。据报告,32例(53%)患者的疼痛为中度至重度,28例(47%)患者的疼痛为轻度至无疼痛。所有患者中有65%,包括近一半中度至重度疼痛患者,报告对当前疼痛控制感到满意。个体患者疼痛管理的平均障碍数为2.6±1.5,33例(55%)患者报告有3个或更多障碍。具体障碍包括80%的患者担心药物副作用,63%的患者不喜欢“药太多”,57%的患者担心药物相互作用,35%的患者害怕成瘾,27%的患者担心掩盖病情。更多障碍与更高的疼痛程度(r = 0.33,P = 0.011)和视觉模拟量表上的疼痛强度(r = 0.29,P = 0.024)显著相关。除37%的患者经常使用非甾体抗炎药和37%的患者使用对乙酰氨基酚外,很少使用镇痛药或其他减轻疼痛的方法。

观点

超过一半的RA患者存在中度至重度疼痛,许多患者报告在疼痛控制方面存在相当大的障碍。这些障碍可能导致疼痛管理欠佳。RA患者耐受疼痛,且使用有限的机制来应对疼痛症状。

相似文献

1
Patient barriers to pain management may contribute to poor pain control in rheumatoid arthritis.类风湿关节炎患者在疼痛管理方面存在的障碍可能导致疼痛控制不佳。
J Pain. 2009 Mar;10(3):300-5. doi: 10.1016/j.jpain.2008.09.012. Epub 2008 Dec 13.
2
Tramadol 37.5-mg/acetaminophen 325-mg combination tablets added to regular therapy for rheumatoid arthritis pain: a 1-week, randomized, double-blind, placebo-controlled trial.将曲马多37.5毫克/对乙酰氨基酚325毫克复方片剂添加到类风湿性关节炎疼痛的常规治疗中:一项为期1周的随机、双盲、安慰剂对照试验。
Clin Ther. 2006 Dec;28(12):2052-60. doi: 10.1016/j.clinthera.2006.12.019.
3
The Danish Barriers Questionnaire-II: preliminary validation in cancer pain patients.丹麦障碍问卷-II:在癌症疼痛患者中的初步验证
Pain Pract. 2009 Jul-Aug;9(4):266-74. doi: 10.1111/j.1533-2500.2009.00296.x. Epub 2009 Jun 22.
4
Impact of transdermal fentanyl on quality of life in rheumatoid arthritis.透皮芬太尼对类风湿关节炎患者生活质量的影响。
Clin J Pain. 2007 Jul-Aug;23(6):530-4. doi: 10.1097/AJP.0b013e318074c9b1.
5
Differences in longitudinal disease and treatment characteristics of patients with rheumatoid arthritis replying and not replying to a postal questionnaire. Experience from a biologics register in southern Sweden.对邮寄问卷调查做出回应和未做出回应的类风湿关节炎患者的纵向疾病及治疗特征差异。瑞典南部生物制剂登记处的经验
J Rheumatol. 2009 Jun;36(6):1166-9. doi: 10.3899/jrheum.081027. Epub 2009 May 1.
6
Barriers to caregiver administration of pain medication in hospice care.临终关怀中照顾者给予止痛药物的障碍。
J Pain Symptom Manage. 2004 Feb;27(2):114-24. doi: 10.1016/j.jpainsymman.2003.06.008.
7
Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).阿片类药物与老年人慢性重度疼痛的管理:一个国际专家小组的共识声明,重点关注世界卫生组织第三阶梯临床最常用的六种阿片类药物(丁丙诺啡、芬太尼、氢吗啡酮、美沙酮、吗啡、羟考酮)。
Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23.
8
Pain severity, satisfaction with pain management, and patient-related barriers to pain management in patients with cancer in Israel.以色列癌症患者的疼痛严重程度、对疼痛管理的满意度以及与患者相关的疼痛管理障碍。
Oncol Nurs Forum. 2011 Jul;38(4):E305-13. doi: 10.1188/11.ONF.E305-E313.
9
Efficacy and tolerability of valdecoxib in treating the signs and symptoms of severe rheumatoid arthritis: a 12-week, multicenter, randomized, double-blind, placebo-controlled study.伐地考昔治疗重度类风湿关节炎体征和症状的疗效及耐受性:一项为期12周的多中心、随机、双盲、安慰剂对照研究。
Clin Ther. 2007 Jun;29(6):1071-85. doi: 10.1016/j.clinthera.2007.06.016.
10
Patient anxiety may influence the efficacy of ED pain management.患者的焦虑可能会影响 ED 疼痛管理的效果。
Am J Emerg Med. 2013 Feb;31(2):313-8. doi: 10.1016/j.ajem.2012.08.009. Epub 2012 Sep 13.

引用本文的文献

1
Flourishing mental health despite disabling chronic pain: Findings from a nationally representative sample of Canadians with arthritis.尽管患有致残性慢性疼痛,但精神健康状况良好:来自加拿大全国关节炎患者代表性样本的研究结果。
PLoS One. 2023 Oct 11;18(10):e0291722. doi: 10.1371/journal.pone.0291722. eCollection 2023.
2
Mechanistic insights into the role of the chemokine CCL2/CCR2 axis in dorsal root ganglia to peripheral inflammation and pain hypersensitivity.趋化因子CCL2/CCR2轴在背根神经节对外周炎症和疼痛超敏反应中的作用的机制性见解。
J Neuroinflammation. 2021 Mar 23;18(1):79. doi: 10.1186/s12974-021-02125-y.
3
Comparing the effect of eye movement desensitization and reprocessing (EMDR) with guided imagery on pain severity in patients with rheumatoid arthritis.
比较眼动脱敏再处理疗法(EMDR)与引导式意象疗法对类风湿性关节炎患者疼痛严重程度的影响。
J Pain Res. 2018 Sep 28;11:2107-2113. doi: 10.2147/JPR.S158981. eCollection 2018.
4
Use of the Orem self-care model on pain relief in women with rheumatoid arthritis: a randomized trial.奥瑞姆自我护理模式用于缓解类风湿关节炎女性患者疼痛的随机试验
Electron Physician. 2018 Jun 25;10(6):6884-6891. doi: 10.19082/6884. eCollection 2018 Jun.
5
Pivotal factors for successful withdrawal of nonsteroidal anti-inflammatory drugs in rheumatoid arthritis patients in remission or with low-disease activity.缓解期或低疾病活动度的类风湿关节炎患者成功停用非甾体抗炎药的关键因素。
Clin Rheumatol. 2018 Feb;37(2):307-314. doi: 10.1007/s10067-017-3863-7. Epub 2017 Oct 8.
6
Evidence and consensus recommendations for the pharmacological management of pain in India.印度疼痛药物治疗的证据与共识建议。
J Pain Res. 2017 Mar 29;10:709-736. doi: 10.2147/JPR.S128655. eCollection 2017.
7
Factors predicting pain and early discontinuation of tumour necrosis factor-α-inhibitors in people with rheumatoid arthritis: results from the British society for rheumatology biologics register.类风湿关节炎患者中预测肿瘤坏死因子-α抑制剂疼痛及早期停药的因素:来自英国风湿病学会生物制剂登记处的结果
BMC Musculoskelet Disord. 2016 Aug 12;17:337. doi: 10.1186/s12891-016-1192-7.
8
Mechanisms, impact and management of pain in rheumatoid arthritis.类风湿关节炎疼痛的机制、影响和管理。
Nat Rev Rheumatol. 2014 Oct;10(10):581-92. doi: 10.1038/nrrheum.2014.64. Epub 2014 May 27.
9
Pharmacotherapeutic management of chronic noncancer pain in primary care: lessons for pharmacists.基层医疗中慢性非癌性疼痛的药物治疗管理:对药剂师的启示。
J Pain Res. 2014 Mar 24;7:163-73. doi: 10.2147/JPR.S56884. eCollection 2014.
10
Sensing the main health concerns in patients with established rheumatoid arthritis.察觉已确诊类风湿关节炎患者的主要健康问题。
Clin Rheumatol. 2011 Nov;30(11):1511-4. doi: 10.1007/s10067-011-1853-8. Epub 2011 Sep 27.